3-D Doppler Ultrasound Helps Identify Breast Cancer
Main Category: Breast CancerAlso Included In: MRI / PET / Ultrasound
Article Date: 22 Oct 2008 - 4:00 PDT
| Patient / Public: | ![]() | |
| Healthcare Prof: | ![]() |
Three-dimensional (3-D) power Doppler ultrasound helps radiologists distinguish between malignant and benign breast masses, according to a new study being published in the November issue of Radiology.
"Using 3-D scans promises greater accuracy due to more consistent sampling over the entire tumor," said lead author, Gerald L. LeCarpentier, Ph.D., assistant professor in the Department of Radiology at University of Michigan in Ann Arbor. "Our study shows that 3-D power Doppler ultrasound may be useful in the evaluation of some breast masses."
Malignant breast masses often exhibit increased blood flow compared to normal tissue or benign masses. Using 3-D power Doppler ultrasound, radiologists are able to detect vessels with higher flow speeds, which likely indicate cancer.
For the study, Dr. LeCarpentier and colleagues studied 78 women between the ages of 26 and 70 who where scheduled for biopsy of a suspicious breast mass. Each of the women underwent a 3-D Doppler ultrasound exam followed by core or excisional biopsy of the breast.
The results showed that 3-D power Doppler ultrasound was highly accurate in identifying malignant breast tumors. When combined with age-based assessment and gray scale visual analysis, 3-D Doppler showed a sensitivity of 100 percent in identifying cancerous tumors and a specificity of 86 percent in excluding benign tumors.
"Using speed-weighted 3-D power Doppler ultrasound, higher flow velocities in the malignant tumor-feeding vessels may be detected, whereas vessels with slower flow velocities in surrounding benign masses may be excluded," Dr. LeCarpentier said.
"Suspicious Breast Lesions: Assessment of 3D Doppler US Indexes for Classification in a Test Population and Fourfold Cross-Validation Scheme." Collaborating with Dr. LeCarpentier were Marilyn A. Roubidoux, M.D., J. Brian Fowlkes, Ph.D., Jochen F. Krücker, Ph.D., Karen A. Hunt, M.D., Chintana Paramagul, M.D., Timothy D. Johnson, Ph.D., Nancy J. Thorson, R.T., R.D.M.S., C.C.R.P., M.F.A., Karen D. Engle, M.L.S., and Paul L. Carson, Ph.D. Journal attribution requested.
Radiology is edited by Herbert Y. Kressel, M.D., Harvard Medical School, Boston, Mass., and owned and published by the Radiological Society of North America, Inc. (RSNA.org/radiologyjnl)
The Radiological Society of North America (RSNA) is an association of more than 41,000 radiologists, radiation oncologists, medical physicists and related scientists committed to excellence in patient care through education and research. (RSNA.org)
For patient-friendly information on MRI, visit http://RadiologyInfo.org.
Source:
Linda Brooks
Radiological Society of North America
Visit our breast cancer section for the latest news on this subject.
MLA
13 Feb. 2012. <http://www.medicalnewstoday.com/releases/126351.php>
APA
http://www.medicalnewstoday.com/releases/126351.php.
Please note: If no author information is provided, the source is cited instead.
|
Rate this article: (Hover over the stars then click to rate) |
Patient / Public: |
or |
Health Professional: |
Add Your Opinion
Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.
If you write about specific medications or operations, please do not name health care professionals by name.
All opinions are moderated before being included (to stop spam)
Contact Our News Editors
For any corrections of factual information, or to contact the editors please use our feedback form.
![]()
Please send any medical news or health news press releases to:
Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.




